← Community Healthcare Trust Inc
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | $2.7m |
$3.5m
+29.00%
|
$4.4m
+25.44%
|
$8.4m
+90.23%
|
$19.1m
+127.76%
|
$22.5m
+17.90%
|
$22.0m
-2.10%
|
$7.7m
-64.97%
|
($3.2m)
-141.24%
|
$5.1m
+260.39%
|
— | |
| Depreciation and amortization | $13.4m | $18.2m | $20.2m | $527k | $25.4m | $30.4m | $32.3m | $39.7m | $42.8m | $43.5m | $44.7m | |
| Other amortization | — | — | $629k | $527k | $136k | $824k | $853k | $746k | $927k | $1.3m | — | |
| Accelerated amortization of stock-based compensation | — | — | — | — | — | $0 | $0 | $11.8m | $0 | $4.6m | — | |
| Deferred income tax expense | $0 | ($478k) | ($1.5m) | $1.4m | $80k | $167k | $41k | $306k | $0 | $23k | $23k | |
| Stock-based compensation | $674k | $1.5m | $2.9m | $3.8m | $4.7m | $7.2m | $9.4m | $8.2m | $10.0m | $10.3m | $10.6m | |
| (Gains) on the sales of depreciable real estate assets, net of losses and impairments | — | — | — | — | — | — | — | $102k | $121k | ($11.8m) | — | |
| Straight-line rent receivables | ($611k) | ($1.3m) | ($1.2m) | ($2.1m) | ($3.2m) | ($3.6m) | ($3.4m) | ($3.1m) | ($1.9m) | ($3.7m) | — | |
| Accounts payable and accrued liabilities | $2.1m | $402k | ($1.3m) | ($95k) | $1.0m | ($438k) | $1.4m | $859k | $2.3m | ($1.2m) | — | |
| Invoices accrued for construction, tenant improvement and other capitalized costs | $28k | $209k | $71k | $385k | $890k | $2.4m | $4.4m | $3.9m | $4.6m | $6.6m | — | |
| Other assets | ($2.0m) | ($1.1m) | ($2.2m) | ($1.8m) | $517k | ($1.3m) | ($1.8m) | ($3.0m) | ($3.3m) | $994k | — | |
| Other liabilities | ($290k) | $1.4m | ($1.5m) | ($124k) | $329k | $829k | ($579k) | ($1.3m) | $221k | ($1.4m) | — | |
| Net cash provided by operating activities | $14.9m |
$22.1m
+48.21%
|
$24.4m
+10.46%
|
$32.4m
+32.41%
|
$48.4m
+49.47%
|
$56.3m
+16.49%
|
$60.3m
+6.98%
|
$61.4m
+1.83%
|
$58.9m
-4.08%
|
$56.4m
-4.16%
|
$59.5m
+5.43%
|
|
| Capital expenditures on existing real estate properties | ($1.6m) | ($1.1m) | ($4.6m) | ($4.4m) | ($7.0m) | ($7.2m) | ($10.4m) | ($19.0m) | ($24.6m) | ($20.5m) | ($20.8m) | |
| Acquisitions of real estate | ($103.2m) | ($133.5m) | ($45.2m) | ($150.0m) | ($126.8m) | ($88.1m) | ($96.7m) | ($98.9m) | ($72.4m) | ($64.6m) | — | |
| Net cash used in investing activities | ($117.1m) | ($147.6m) | ($53.5m) | ($153.2m) | ($125.1m) | ($104.4m) | ($113.8m) | ($113.7m) | ($92.7m) | ($47.7m) | ($65.8m) | |
| Net borrowings on revolving credit facility | $34.0m | ($17.0m) | $9.0m | ($28.0m) | ($18.0m) | ($21.0m) | ($12.0m) | $50.0m | $162.0m | $46.0m | — | |
| Debt issuance costs | ($634k) | ($743k) | ($326k) | ($1.3m) | $0 | ($1.6m) | ($844k) | $0 | ($3.4m) | $0 | — | |
| Proceeds from issuance of common stock | $86.8m | $109.2m | $10.2m | $107.2m | $98.0m | $38.4m | $20.5m | $44.2m | $7.5m | $0 | $0 | |
| Dividends paid | ($17.8m) | ($24.4m) | ($29.4m) | ($31.9m) | ($38.0m) | ($42.4m) | ($44.5m) | ($48.1m) | ($51.7m) | ($53.7m) | ($54.4m) | |
| Net cash (used in) provided by financing activities | $101.7m |
$126.0m
+23.87%
|
$29.3m
-76.72%
|
$120.4m
+310.68%
|
$77.6m
-35.61%
|
$48.1m
-38.04%
|
$62.7m
+30.46%
|
$44.9m
-28.45%
|
$33.5m
-25.24%
|
($9.8m)
-129.16%
|
— | |
| (Decrease) increase in fair value of cash flow hedges | $0 | $144k | $182k | ($5.5m) | ($9.9m) | $2.4m | $27.4m | $3.8m | $11.6m | ($3.9m) | — | |
| Cash, cash equivalents and restricted cash, beginning of period | $1.6m | $2.1m | $2.4m | $2.0m | $2.9m | $2.9m | $12.1m | $4.6m | $4.4m | $3.3m | — | |
| Decrease in cash, cash equivalents and restricted cash | ($450k) | $562k | $262k | ($369k) | $869k | ($25k) | $9.2m | ($7.4m) | ($249k) | ($1.0m) | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Credit loss reserve | — | — | — | — | — | — | $0 | $0 | $11.0m | $8.7m | — | |
| Net gain from insurance recovery on casualty loss | — | — | — | — | — | $0 | $0 | ($706k) | $0 | $0 | — | |
| Proceeds from the sale of real estate | — | — | — | — | — | $1.3m | $0 | $0 | $2.3m | $32.2m | — | |
| Funding of notes receivable | $0 | $0 | ($4.8m) | $0 | $0 | ($14.3m) | ($9.7m) | ($2.0m) | ($3.1m) | $0 | — | |
| Proceeds from repayments on notes receivable | $104k | $833k | $92k | $1.2m | $10.3m | $4.0m | $3.0m | $3.9m | $5.1m | $5.2m | — | |
| Insurance proceeds from casualty loss | — | — | — | — | — | $0 | $0 | $2.3m | $0 | $0 | — | |
| Term loan repayments | — | — | — | $0 | $0 | ($50.0m) | ($50.0m) | $0 | ($75.0m) | $0 | — | |
| Mortgage note repayments | — | $0 | $0 | ($103k) | ($108k) | ($104k) | ($130k) | ($126k) | ($4.8m) | $0 | — | |
| Taxes paid on behalf of employees and shares withheld upon shares vesting | — | — | — | — | — | $0 | $0 | ($963k) | ($785k) | ($1.8m) | — | |
| Equity issuance costs | ($680k) | ($611k) | ($157k) | ($449k) | ($269k) | ($216k) | ($392k) | ($227k) | ($223k) | ($317k) | — | |
| Interest paid | $564k | $3.1m | $5.6m | $8.8m | $8.1m | $10.0m | $11.2m | $17.1m | $23.1m | $25.9m | $27.2m | |
| Reclassification of registration statement costs to equity issuance costs | — | — | — | — | — | — | — | $197k | $354k | $175k | — | |
| Capitalized interest | — | — | — | $0 | $111k | $279k | $672k | $611k | $216k | $210k | — |